The authors treated 12 consecutive bulimic patients with nomifensine, a
novel antidepressant recently approved for American use. Two patients
developed fever, necessitating discontinuation of the drug. Of the other 10
patients, nine showed moderate or better improvement, with strikingly few
side effects.
Abstract Teaser